Edwin Rock, Chief Medical Officer at GLYCOMIMETICS INC (GLYC), bought 110,000 shares at $2.25 ($248K) on 2022-12-22, disclosed to the SEC on 2022-12-27.
Open-market purchase of $248k GLYC by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| GLYC | BUY | 2022-11-16 | $309K | — | Filing → |